Tactile Systems [TCMD] vs Abbott Laboratories [ABT] Detailed Stock Comparison

Tactile Systems Technology Inc.

NASDAQ
Loading...

Abbott Laboratories

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Tactile Systems Technology Inc. wins in 9 metrics, Abbott Laboratories wins in 10 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Tactile Systems Technology Inc. Abbott Laboratories Better
P/E Ratio (TTM) 30.45 25.97 Abbott Laboratories
Price-to-Book Ratio 2.56 3.09 Tactile Systems Technology Inc.
Debt-to-Equity Ratio 7.29 26.79 Tactile Systems Technology Inc.
PEG Ratio 1.74 -1.41 Tactile Systems Technology Inc.
EV/EBITDA 13.61 13.74 Tactile Systems Technology Inc.
Profit Margin (TTM) 5.79% 13.90% Abbott Laboratories
Operating Margin (TTM) 18.12% 16.50% Tactile Systems Technology Inc.
EBITDA Margin (TTM) 18.12% 16.50% Tactile Systems Technology Inc.
Return on Equity 8.77% 12.36% Abbott Laboratories
Return on Assets (TTM) 6.40% 7.52% Abbott Laboratories
Free Cash Flow (TTM) $40.28M $7.40B Abbott Laboratories
Dividend Yield N/A 1.97% N/A
1-Year Return 167.38% -34.98% Tactile Systems Technology Inc.
Price-to-Sales Ratio (TTM) 1.72 3.57 Tactile Systems Technology Inc.
Enterprise Value $489.00M $166.96B Abbott Laboratories
EV/Revenue Ratio 1.48 3.70 Tactile Systems Technology Inc.
Gross Profit Margin (TTM) 78.20% N/A N/A
Revenue per Share (TTM) $14 $26 Abbott Laboratories
Earnings per Share (Diluted) $0.82 $3.57 Abbott Laboratories
Beta (Stock Volatility) 0.99 0.78 Abbott Laboratories
Short % of Float 7.47% 1.53% Abbott Laboratories

Tactile Systems Technology Inc. vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

TCMD
ABT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Tactile Systems Technology Inc.0.19%4.40%15.92%-3.44%-7.28%-3.80%
Abbott Laboratories0.56%-2.02%4.97%-19.35%-30.98%-28.60%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Tactile Systems Technology Inc.167.38%7.74%-48.14%133.66%133.66%133.66%
Abbott Laboratories-34.98%-16.97%-20.08%135.84%255.56%329.52%

Performance & Financial Health Analysis: Tactile Systems Technology Inc. vs Abbott Laboratories

MetricTCMDABT
Market Information
Market Cap i$556.25M$160.70B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i184,11513,495,583
90 Day Avg. Volume i235,54812,934,461
Last Close$26.36$88.67
52 Week Range$9.41 - $37.77$81.97 - $139.06
% from 52W High-30.21%-36.24%
All-Time High$76.63 (Feb 18, 2019)$142.60 (Dec 27, 2021)
% from All-Time High-65.60%-37.82%
Growth Metrics
Quarterly Revenue Growth0.21%0.08%
Quarterly Earnings Growth0.09%-0.19%
Financial Health
Profit Margin (TTM) i0.06%0.14%
Operating Margin (TTM) i0.18%0.17%
Return on Equity (TTM) i0.09%0.12%
Debt to Equity (MRQ) i7.2926.79
Cash & Liquidity
Book Value per Share (MRQ)$9.76$30.02
Cash per Share (MRQ)$3.72$5.14
Operating Cash Flow (TTM) i$42.81M$10.80B
Levered Free Cash Flow (TTM) i$34.58M$13.77B
Dividends
Last 12-Month Dividend Yield iN/A1.97%
Last 12-Month Dividend iN/A$2.40

Valuation & Enterprise Metrics Analysis: Tactile Systems Technology Inc. vs Abbott Laboratories

MetricTCMD (Apr 24, 2026)ABT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i30.4525.97
Forward P/E i16.9315.29
PEG Ratio i1.74-1.41
Price to Sales (TTM) i1.723.57
Price to Book (MRQ) i2.563.09
Market Capitalization
Market Capitalization i$556.25M$160.70B
Enterprise Value i$489.00M$166.96B
Enterprise Value Metrics
Enterprise to Revenue i1.483.70
Enterprise to EBITDA i13.6113.74
Risk & Other Metrics
Beta i0.990.78
Book Value per Share (MRQ) i$9.76$30.02

Financial Statements Comparison: Tactile Systems Technology Inc. vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTCMD (2025)ABT (2025)
Revenue/Sales i329.52M44.33B
Cost of Goods Sold i79.38M19.32B
COGS % of Revenue i24.1%43.6%
Gross Profit i250.15M25.01B
Gross Margin i75.9%56.4%
Research & Development i8.48M2.94B
Operating Income (EBIT) i29.28M8.05B
Operating Margin i8.9%18.2%
EBITDA i39.02M12.03B
EBITDA Margin i11.8%27.1%
Pre-Tax Income i31.34M8.47B
Pre-Tax Income % of Revenue i9.5%19.1%
Income Tax i12.25M1.94B
Income Tax % of Revenue i3.7%4.4%
Net Income (Profit) i19.09M6.52B
Profit Margin i5.8%14.7%

Balance Sheet & Liquidity Metrics

MetricTCMD (2025)ABT (2025)
Cash & Equivalents i83.45M8.52B
Total Current Assets i165.17M26.00B
Total Current Assets % of Revenue i50.1%58.6%
Total Current Liabilities i40.96M16.50B
Total Current Liabilities % of Revenue i12.4%37.2%
Long-Term Debt i12.76M10.83B
Long-Term Debt % of Revenue i3.9%24.4%
Total Shareholders Equity i218.90M52.77B
Retained Earnings i54.94M49.78B
Retained Earnings % of Revenue i16.7%112.3%
Property, Plant & Equipment i25.38M17.57B

Cash Flow Statement Comparison

MetricTCMD (2025)ABT (2025)
Operating Cash Flow i46.20M10.80B
Operating Cash Flow % of Revenue i14.0%24.4%
Capital Expenditures i-2.38M-2.17B
Free Cash Flow i40.28M7.40B
FCF Margin i12.2%16.7%
Debt Repayment i-26.25M-1.50B
Common Stock Repurchase i-26.56M-893.00M

Short Interest & Institutional Ownership Analysis

MetricTCMDABT
Shares Short i1.67M23.83M
Short Ratio i6.161.93
Short % of Float i7.47%1.53%
Shares Outstanding i22.44M1.74B
Float Shares i22.08M1.73B
% Held by Insiders i2.08%0.54%
% Held by Institutions i98.44%82.23%
% Held by Public i-0.52%17.23%

Dividend Analysis & Yield Comparison: Tactile Systems Technology Inc. vs Abbott Laboratories

MetricTCMDABT
Last 12-Month Dividend iN/A$2.40
Last 12-Month Dividend Yield iN/A1.97%
3-Year Avg Annual Dividend iN/A$2.24
3-Year Avg Dividend Yield iN/A0.50%
3-Year Total Dividends iN/A$6.72
Ex-Dividend DateN/AJan 15, 2026